Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis

被引:472
|
作者
Trapp, Bruce D. [1 ]
Stys, Peter K. [2 ]
机构
[1] Lerner Res Inst, Cleveland Clin, Dept Neurosci NC30, Cleveland, OH 44195 USA
[2] Univ Calgary, Dept Clin Neurosci, Hotchkiss Brain Inst, Calgary, AB, Canada
来源
LANCET NEUROLOGY | 2009年 / 8卷 / 03期
关键词
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MAGNETIC-RESONANCE-SPECTROSCOPY; CORD WHITE-MATTER; ADAPTIVE FUNCTIONAL-CHANGES; NITRIC-OXIDE; NMDA RECEPTORS; NEUROLOGICAL DISABILITY; GLUTAMATE RECEPTORS; MYELINATED AXONS; SODIUM-CHANNELS;
D O I
10.1016/S1474-4422(09)70043-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multiple sclerosis (MS), an inflammatory demyelinating disease, is a major cause of neurological disability in young adults in the developed world. Although the progressive neurological disability that most patients with MS eventually experience results from axonal degeneration, little is known about the mechanisms of axonal injury in MS. Accumulating evidence suggests that the increased energy demand of impulse conduction along excitable demyelinated axons and reduced axonal ATP production induce a chronic state of virtual hypoxia in chronically demyelinated axons. In response to such a state, key alterations that contribute to chronic necrosis of axons might include mitochondrial dysfunction (due to defective oxidative phosphorylation or nitric oxide production), Na+ influx through voltage-gated Na+ channels and axonal AMPA receptors, release of toxic Ca2+ from the axoplasmic reticulum, overactivation of ionotropic and metabotropic axonal glutamate receptors, and activation of voltage-gated Ca2+ channels, ultimately leading to excessive stimulation of Ca2+-dependent degradative pathways. The development of neuroprotective therapies that target these mechanisms might constitute effective adjuncts to currently used immune-modifying agents.
引用
收藏
页码:280 / 291
页数:12
相关论文
共 50 条
  • [31] The virtual multiple sclerosis patient
    Sorrentino, P.
    Pathak, A.
    Ziaeemehr, A.
    Lopez, E. Troisi
    Cipriano, L.
    Romano, A.
    Sparaco, M.
    Quarantelli, M.
    Banerjee, A.
    Sorrentino, G.
    Jirsa, V.
    Hashemi, M.
    ISCIENCE, 2024, 27 (07)
  • [32] Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis
    Pomeroy, IM
    Matthews, PM
    Frank, JA
    Jordan, EK
    Esiri, MM
    BRAIN, 2005, 128 : 2713 - 2721
  • [33] Morphometric analysis of axons in the minute multiple sclerosis lesions and shadow plaques in patients with multiple sclerosis
    Nowacki, P
    Potemkowski, A
    Korwin-Piotrowska, T
    Nocon, D
    FOLIA NEUROPATHOLOGICA, 2000, 38 (03): : 104 - 110
  • [34] Metabolic support of axons by oligodendrocytes: Implications for multiple sclerosis
    Campbell, Graham R.
    Mahad, Don J.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2014, 3 (01) : 28 - 30
  • [35] Mitochondrial changes within axons in multiple sclerosis: an update
    Campbell, Graham R.
    Ohno, Nobuhiko
    Turnbull, Doug M.
    Mahad, Don J.
    CURRENT OPINION IN NEUROLOGY, 2012, 25 (03) : 221 - 230
  • [36] Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis
    Gray, E.
    Thomas, T. L.
    Scolding, N. J.
    Betmouni, S.
    Love, S.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2008, 34 : 7 - 8
  • [37] Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis
    Sedel, Frederic
    Bernard, Delphine
    Mock, Donald M.
    Tourbah, Ayman
    NEUROPHARMACOLOGY, 2016, 110 : 644 - 653
  • [38] Hypoxia in multiple sclerosis; is it the chicken or the egg?
    Halder, Sebok K.
    Milner, Richard
    BRAIN, 2021, 144 : 402 - 410
  • [39] CHRONIC MULTIPLE SCLEROSIS
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1949, 139 (13): : 896 - 896
  • [40] CONDUCTION IN DEMYELINATED NERVE FIBERS - THEORETICAL BASIS FOR EFFECTS OF TEMPERATURE AND HYPOCALCEMIA IN MULTIPLE SCLEROSIS
    SCHAUF, CL
    DAVIS, FA
    NEUROLOGY, 1973, 23 (04) : 443 - &